News

OpenAI dominates AI via Microsoft & Apple. The DMA falls short – Europe needs rules, freedom of choice and real alternatives, says Hartmut Gieselmann.
China has said it's evaluating approaches from US officials to start negotiations about tariffs, a potential deescalation in ...
which suggested that the Act was part of a strategy “to eliminate competition and strengthen [US] monopoly in the DNA sequencing market.” The article also suggested that the Act was a broader ...
Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).